SCHEMBL12729453

SCHEMBL12729453

CCO[C@@H]1C(C(=O)O)O[C@@H](O[C@H]2C(OS(=O)(=O)O)C(OS(=O)(=O)O)[C@@H](OC)O[C@H]2COS(=O)(=O)O)C(OC)[C@H]1OC

nearest known ligand 0.74

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SERPINC1 P01008 3/20 0.74
▸ F10 P00742 6/20 0.52
▸ FGF1 P05230 4/20 0.51
▸ FGF2 P09038 1/20 0.46
▸ F2 P00734 1/20 0.46
▸ HPSE Q9Y251 4/20 0.45
▸ BDNF P23560 2/20 0.42
▸ PTN P21246 1/20 0.42
▸ MDK P21741 1/20 0.42
▸ CXCL10 P02778 1/20 0.39
▸ CXCL8 P10145 1/20 0.39
▸ CCL2 P13500 1/20 0.39
▸ CCL5 P13501 1/20 0.39
▸ CXCL12 P48061 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29407493 0.92 SERPINC1 (0.85) SERPINC1F10FGF1FGF2F2
Idraparinux SCHEMBL427808 0.92 SERPINC1 (0.85) SERPINC1F10FGF1FGF2F2
Idraparinux SCHEMBL29382311 0.92 SERPINC1 (0.85) SERPINC1F10FGF1FGF2F2
SCHEMBL12458587 0.87 SERPINC1 (0.75) SERPINC1F10FGF1FGF2F2
SCHEMBL15896273 0.86 SERPINC1 (0.69) SERPINC1F10FGF1FGF2F2
SCHEMBL12799309 0.84 SERPINC1 (0.68) SERPINC1F10FGF1FGF2F2
SCHEMBL4732494 0.82 SERPINC1 (0.66) SERPINC1F10FGF1FGF2F2
SCHEMBL13551204 0.82 SERPINC1 (0.66) SERPINC1F10FGF1FGF2F2
SCHEMBL29890443 0.82 SERPINC1 (0.65) SERPINC1F10FGF1FGF2F2
SCHEMBL16316488 0.82 FGF1 (0.64) SERPINC1F10FGF1FGF2HPSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7919614-B2 Disaccharide sequences formed by uronic acid and hexose as to form polysaccharides of 8-24 monosaccharide units whose hydroxyl groups are substituted by alkyl or sulphate groups; possible to modulate activities of glycosaminoglycans type SANOFI-AVENTIS (FR) 2011-04-05 — — US disclosed
Send feedback